TAKE ON PH1

Serial Number 88803039
602

Registration Progress

Application Filed
Feb 19, 2020
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

TAKE ON PH1

Basic Information

Serial Number
88803039
Filing Date
February 19, 2020
Abandonment Date
June 3, 2021
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Jun 15, 2021
Classes
035 041 044

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
300 Third Street, 3rd Floor
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Legal Representation

Attorney
Ann Lamport Hammitte

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

17 events
Date Code Type Description
Jun 15, 2021 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 15, 2021 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Dec 2, 2020 CNFR R FINAL REFUSAL WRITTEN
Dec 2, 2020 GNFR O FINAL REFUSAL E-MAILED
Dec 2, 2020 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 12, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 12, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 12, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 10, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 10, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 10, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 12, 2020 CNRT R NON-FINAL ACTION WRITTEN
May 12, 2020 GNRT F NON-FINAL ACTION E-MAILED
May 12, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 6, 2020 DOCK D ASSIGNED TO EXAMINER
Feb 24, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 22, 2020 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 035
Promoting public awareness about primary hyperoxaluria among affected individuals and their families
First Use Anywhere: 0
First Use in Commerce: 0
Class 041
Educational services, namely, providing education information for training medical professionals and patients regarding primary hyperoxaluria
First Use Anywhere: 0
First Use in Commerce: 0
Class 044
Providing medical information about primary hyperoxaluria
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
TAKE ON PH ONE
Pseudo Mark
TAKE ON PRIMARY HYPEROXALURIA 1

Classification

International Classes
035 041 044